Annals of Clinical Biochemistry

Papers
(The TQCC of Annals of Clinical Biochemistry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Best practice in statistics: The use of log transformation73
Best practice in statistics: Use the Welch t-test when testing the difference between two groups56
Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection39
Correlating arterial blood gas, acid–base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients32
Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens32
Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study29
Serum biomarkers for prediction of mortality in patients with COVID-1923
Identifying mislabelled samples: Machine learning models exceed human performance18
Clinical adoption of Nephrocheck® in the early detection of acute kidney injury17
Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care17
Evaluation of the usability of various rapid antibody tests in the diagnostic application for COVID-1917
Method-dependent variation in TSH and FT4 reference intervals in pregnancy: A systematic review16
Performance verification of anti-SARS-CoV-2-specific antibody detection by using four chemiluminescence immunoassay systems16
The use of whole blood capillary samples to measure 15 analytes for a home-collect biochemistry service during the SARS-CoV-2 pandemic: A proposed model from North West London Pathology15
An LC-MS/MS assay for analysis of equilibrium angiotensin II in human serum13
Reference values for C-reactive protein and procalcitonin at term pregnancy and in the early postnatal period13
Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy13
Negative interference from immunoglobulin M paraproteinaemia on the Roche enzymatic creatinine method10
Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)10
Machine learning predictive models of LDL-C in the population of eastern India and its comparison with directly measured and calculated LDL-C10
Calculated globulin as a screening tool for hypogammaglobulinaemia or paraproteins in hospitalized patients9
Drug dosing using estimated glomerular filtration rate: Misclassification due to metamizole interference in a creatinine assay8
Co-analysis of pancreatic cyst fluid carcinoembryonic antigen and glucose with novel cut-off levels better distinguishes between mucinous and non-mucinous neoplastic pancreatic cystic lesions8
Tumour markers in prostate cancer: The post-prostate-specific antigen era8
Assessing bone formation in patients with chronic kidney disease using procollagen type I N-terminal propeptide (PINP): The choice of assay makes a difference8
Replicate and repeat faecal immunochemical tests in symptomatic patients: A systematic review7
Clinical laboratory medicine measurements correlation analysis under uncertainty7
Can artificial intelligence replace biochemists? A study comparing interpretation of thyroid function test results by ChatGPT and Google Bard to practising biochemists7
The use of routine blood tests to assist the diagnosis of COVID-19 in symptomatic hospitalized patients7
Biological sources of variations of tartrate-resistant acid phosphatase 5b in a healthy Japanese population7
Reflex and reflective testing: progress, but much still to be done7
Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers6
SARS-CoV-2 (Covid-19): A short update on molecular biochemistry, pathology, diagnosis and therapeutic strategies6
SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?6
Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole6
Development, validation, and application of an UPLC-MS/MS method for vancomycin, norvancomycin, methotrexate, paclitaxel, and imatinib analysis in human plasma6
Pneumatic tube validation: Reducing the need for donor samples by integrating a vial-embedded data logger6
Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarction6
The association between acid–base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosis6
Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state6
Case report: Interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient5
A rapid LC-MS/MS assay for the measurement of serum methotrexate in patients who have received high doses for chemotherapy5
Management of transgender patients in Laboratory Information Management Systems – Moving on from binary and ternary logic5
The effect of haemolysis on the direct and indirect ion selective electrode measurement of sodium5
Performance of commercially-available cholesterol self-tests5
Conflicting effects of haemolysis on plasma sodium and chloride are due to different haemolysis study protocols: A case for standardisation4
Effects of bilirubin configurational photoisomers on the measurement of direct bilirubin by the vanadate oxidation method4
Analytical characterization and clinical performance evaluation of a new point-of-care testing system for high-sensitivity cardiac troponin I assay4
Do faecal test-based colorectal cancer screening pilots provide data that are reflected in subsequent programmes? Evidence from interval cancer proportions4
Application of the sigma metrics to evaluate the analytical performance of cystatin C and design a quality control strategy4
Alternative diagnoses and demographics associated with a raised quantitative faecal immunochemical test in symptomatic patients4
Trimester-specific reference intervals for cystatin C and neutrophil gelatinase-associated lipocalin during pregnancy4
Reference intervals of urinary kidney injury biomarkers for middle-aged men and women determined by quantitative protein mass spectrometry4
Assessment of the analytical performance of point-of-care faecal immunochemical tests for haemoglobin4
Survey of patient perception of pre-analytical requirements for blood testing in the UK and RoI4
Multiple biomarkers measurement to estimate the duration of atrial fibrillation4
Does the use of fish oil-based lipid emulsion in the clinical setting of total parenteral nutrition and lipid rescue therapy interfere with common laboratory analytes on Roche Cobas 6000?4
Factors influencing the derivation and clinical application of blood calcium adjustment equations4
Lithium heparin interference in the Abbott enzymatic creatinine assay: the significance of under-filled tubes3
National recommendations to standardise acute kidney injury detection and alerting3
“Macro transcobalamin causing raised vitamin B12: Case-based laboratory investigation"3
Repeat measurements on patient samples identifies unpredictable and poorly reproducible cardiac troponin results with a high-sensitivity cardiac troponin assay3
MicroRNA in the diagnosis of lung cancer: An overview of ten systematic reviews3
Correlation of serum myonectin concentrations with the presence and severity of obstructive sleep apnoea syndrome3
Personalising laboratory medicine in the ‘real world’: Assessing clinical utility, by clinical indication, of serum total B12 and Active-B12® (holotranscobalamin) in the diagnosi3
Determination of a Beckman Coulter AU turbidometric method-specific caeruloplasmin reference interval3
Diagnostic performance of serum calprotectin in discriminating active from inactive ulcerative colitis in an outpatient setting3
Serum cortisol assay performance following the 1 mg overnight dexamethasone suppression test3
Predicting ionized hypocalcemia: External validation of an ionized calcium prediction model in patients with COVID-19 and renal failure3
Time-resolved fluorescence immunoassay for urine retinol-binding protein is more sensitive than polyclonal and monoclonal assays3
UK National audit of the measurement of ammonia3
Reference intervals for clinical biochemistry and haematology tests during normal pregnancy3
Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS/MS and assessment of diagnostic performance in pheochromocytoma/paraganglioma3
Key methodological challenges in detecting circulating miRNAs in different biofluids3
Implementing cardiovascular precision diagnostics: laboratory specialists as catalysts?3
Routine use of natriuretic peptides: Lessons from a big data analysis3
Variation of eGFR reporting and CKD equations used in the United Kingdom3
Can patients with mild post-operative hyponatraemia following elective arthroplasty be discharged safely? A large-scale service evaluation suggests they can3
Novel cholesterol efflux assay using immobilized liposome-bound gel beads: Confirmation and improvement for application in clinical laboratory3
Standardising the biochemical confirmation of adult male hypogonadism; a joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine*3
Falsely elevated thyroid hormone levels associated with fibrin interference in patients receiving oral anticoagulant therapy3
A standard addition method to quantify serum lithium by inductively coupled plasma mass spectrometry3
0.03077507019043